Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval

Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy. “It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up…

Major Trial Finds MDMA-Assisted Therapy Is Effective for PTSD, Paving Way for FDA Approval

The results of a Phase III trial published this week could soon lead to a new era for the treatment of post-traumatic stress disorder. The study found that a combination of MDMA and psychotherapy was effective at relieving PTSD symptoms when compared to standard therapy. The nonprofit organization funding this…Read more...

Success of MDMA in PTSD Study Could Pave the Way for U.S. Approval

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy. “It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up…

Psychedelic Drug MDMA Eases PTSD Symptoms in a Study That Paves the Way for Possible US Approval

A study has found that the psychedelic drug MDMA, combined with talk therapy, can reduce symptoms of post-traumatic stress disorder.

Psychedelic drug MDMA eases PTSD symptoms, study says; seeking US approval

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.

Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. “It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.